Cardiovascular Inflammation Reduction Trial

NCT01594333 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4786

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease

Interventions

DRUG: Methotrexate
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]